Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
The Effect of Semaglutide on Antipsychotic-Induced Weight Gain and Other Metabolic Parameters, among a Cohort of Inpatients
Schizophrenia bulletin;52(3)
Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management
American family physician;113(6):578-585
Cost-Effectiveness of Pharmacologic Treatments in Adults With Overweight or Obesity: A Systematic Review for the American College of Physicians
Annals of internal medicine, 2026
Benefits and Harms of Pharmacologic Treatments in Adults With Overweight or Obesity: A Living Systematic Review and Network Meta-analysis for the American College of Physicians
Annals of internal medicine, 2026
Pharmacologic Treatments With Lifestyle Modifications in Nonpregnant Adults With Overweight or Obesity in Outpatient Settings: A Living Clinical Guideline From the American College of Physicians (April 2026)
Annals of internal medicine, 2026
Cardiovascular Outcomes in a SELECT-Like Obesity Cohort: Real-World Insights From the Swedish AROS Database
Diabetes, obesity & metabolism, 2026
Tirzepatide for Excess Weight in Adults With Type 1 Diabetes Using MiniMed 780G
Diabetes, obesity & metabolism, 2026
Comparative Effects of Antidiabetic Drugs on Body Composition: A Systematic Review and Network Meta-Analysis
Diabetes, obesity & metabolism, 2026
Tirzepatide for Obesity in Adults ≥ 65 Years: A Post Hoc Analysis of the SURMOUNT and SUMMIT Clinical Trials
Diabetes, obesity & metabolism, 2026
Comparison of Specific Glucagon-Like Peptide-1 Receptor Agonists on Kidney Outcomes Among Patients With Type 2 Diabetes
American journal of kidney diseases : the official journal of the National Kidney Foundation, 2026
Association between GLP-1 receptor agonist use and NAION with optic disc drusen
Ophthalmology, 2026
Weight-loss dynamics with tirzepatide versus semaglutide
PNAS nexus, 2026;5(6):pgag171
Tirzepatide and the Cardiovascular Continuum: Metabolic, Cardiorenal and Heart Failure Evidence
Clinical Medicine Insights. Cardiology, 2026;20:11795468261460202
Prospects for Neuroprotective Therapies in Glaucoma: Drug Targets and Emerging Clinical Strategies
Drug design, development and therapy, 2026;20:612176
Prioritizing Antidiabetic Drugs for Inflammatory Bowel Disease Through Inverse Signal Detection: A FAERS Pharmacovigilance Study
Journal of clinical medicine, 2026;15(12)
Urological Complications of Morbid Obesity and the Role of Bariatric Surgery and Glucagon-Like Peptide-1 Receptor Agonists in Their Management: A Systematic Review
Cureus, 2026;18(6):e110952
Acute Nutritional Axonal Neuropathy in the Setting of Semaglutide-Associated Gastrointestinal Intolerance: A Case Report
Case reports in neurology, 2026;18(1):402-412
Real-world use of oral semaglutide in adults with type 2 diabetes
Danish medical journal, 2026;73(7)
Cardiometabolic Effects of Semaglutide in Individuals with Type 2 Diabetes in the United Arab Emirates: Real-World 12-Month Outcomes and Predictors of Response
Diabetes therapy : research, treatment and education of diabetes and related disorders, 2026
GLP-1 Receptor Agonists in Aesthetic Surgery: A Narrative Review on Perioperative Safety, Sarcopenic Morphologies, and Adapted Body Contouring Strategies
Aesthetic plastic surgery, 2026